<DOC>
	<DOC>NCT02996396</DOC>
	<brief_summary>Multicenter, single arm, open label, registry study with consecutive, eligible patient enrollment at each site. All subjects undergoing the Endovascular Aneurysm Sealing System (EVAS) with the NellixÂ®-System. Subjects will be followed procedurally to discharge, and as per institutional standard of care thereafter through to 5 years (total follow-up commitment)</brief_summary>
	<brief_title>Nellix Registry Study: EVAS-Global</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
	<criteria>1. Male or female at least 18 years old 2. Subject has signed informed consent for data release 3. Subjects with with AAA and eligible for endovascular repair 1. Currently participating in another study where primary endpoint has not been reached yet 2. Known allergy to any of the device components 3. Pregnant (females of childbearing potential only)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>AAA, Aortoiliac Aneurysm</keyword>
</DOC>